Specialty Pharma Journal Specialty, Precision & Technology
No job listings found.
Breaking News
- FDA Grants Orphan Drug Designation to Lynparza for Treatment of Pancreatic Cancer
- Cannabics Announces Positive Results for Pilot Study on Treatment of Cancer Anorexia-Cachexia Syndrome
- Scripps Research Translational Institute Collaborates with Seqster To Bring Genetic Risk Scores With Health Data
- Gottlieb Makes Statement on FDA’s New Steps to Modernize Drug Development, Improve Efficiency and Promote Innovation of Targeted Therapies
- Alnylam to Initiate Rolling Submission of NDA and Pursue Full Approval for Givosiran for Acute Hepatic Porphyria
- Genentech’s Kadcyla Reduced the Risk of Disease Recurring in People With HER2-Positive Early Breast Cancer With Residual Disease After Neoadjuvant Treatment
- FDA Grants Breakthrough Therapy Designation to Loxo Oncology’s Investigational LOXO-292 for RET Fusion-Positive Thyroid Cancer
- Bristol-Myers Squibb’s Opdivo Fails to Meet Primary Endpoint in Phase 3 Study in Patients with Relapsed Small Cell Lung Cancer
- Bristol-Myers Squibb and Compugen Partner to Evaluate Therapeutic Regimen in Advanced Solid Tumors
- FDA Grants Orphan Drug Designation to Synspira’s Investigational Cystic Fibrosis Therapy